NCT01600365

Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus

"Prospective, Interventional, Randomized, Double-masked With the Use of Ganciclovir Gel 0.3% for Treatment of Conjunctivitis Caused by Adenovirus."

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 22 (estimated)
• Sponsor: Adapt Produtos Oftalmológicos Ltda. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to study the use of ganciclovir gel 0.3% for treatment of conjunctivitis caused by adenovirus.

Detailed description

To evaluate the efficacy and tolerability of ganciclovir ophthalmic gel for the treatment of conjunctivitis comparing to placebo (ophthalmic gel). Visual acuity test and slit lamp examination (biomicroscopy) will be performed at each visit to assess the signs/symptoms and the regression of the disease.

Conditions

• Conjunctivitis
• Adenovirus.

Interventions

Type	Name	Description
DRUG	Ophthalmic gel (placebo)	Ophthalmic gel (placebo): applied in affected eye 4 times daily for 10 days
DRUG	Ganciclovir	Ophthalmic gel ganciclovir 0,3%: applied in affected eye 4 times daily for 10 days

Timeline

• Start date: 2012-05-01
• Primary completion: 2012-06-01
• Completion: 2012-06-01
• First posted: 2012-05-17
• Last updated: 2012-05-17